Kamilla Miskowiak is Professor of Cognitive Neuropsychiatry in the Department of Psychology, University of Copenhagen, Copenhagen, Denmark, and Head of the Neurocognition and Emotion in Affective Disorders (NEAD) Group based at the Psychiatric Centre Copenhagen, Copenhagen University Hospital, Copenhagen, Denmark. The NEAD group conducts clinical and experimental studies in patients with mood disorders using neurocognitive testing, clinical ratings and neuroimaging. They aim to identify new treatments targeting cognitive impairments in mood disorders and to delineate the mechanisms of established and novel candidate treatments. In addition, the group uses the Danish twin registers to study the effects of genetic risk of mood disorder on neurocognitive and neuroimaging measures. Kamilla Miskowiak has a degree in Psychology from the University of Copenhagen (2006) with a dissertation on multidisciplinary research in depression, which received the university gold medal. An MSc (with distinction) (2004), a DPhil (PhD) (2008) from the University of Oxford, Oxford, UK, in Experimental Psychology and Psychiatry and a DMSc (2018) from the University of Copenhagen. She is an author of >170 peer-reviewed articles in leading international journals in the field, including Biological Psychiatry, Journal of Neuroscience and Nature Communications.

Moderator Of 1 Session

Session Type
Industry
Date
Mon, 06.06.2022
Session Time
13:00 - 14:30
Room
Industry session hall 1
Session Description
Progress in the identification and management of TRD and psychiatric emergencies due to MDD-Supported by Janssen Pharmaceutical NV

Session Description:

The different facets of TRD and MDD-related psychiatric emergencies:
- Discuss the available guidelines and definitions for TRD
- Overview of psychiatric emergencies due to MDD
Novel techniques in the identification of TRD and MDD-related psychiatric emergencies:
- Discuss the importance of early detection in improving outcomes for patients with MDD/TRD
- Overview of psychiatric assessment for TRD and MDD-related psychiatric emergencies
Fast-acting treatments: progress in the management of TRD and MDD-related psychiatric emergencies:
- Discuss the importance of appropriate escalation strategies in the treatment of MDD/TRD and MDD-related psychiatric emergencies
- Overview of treatment process and timeline

Session Icon
Fully Live

Presenter Of 3 Presentations

Welcome and introduction

Session Type
Industry
Date
Mon, 06.06.2022
Session Time
13:00 - 14:30
Room
Industry session hall 1
Session Icon
Fully Live
Lecture Time
13:00 - 13:05

Audience Q&A

Session Type
Industry
Date
Mon, 06.06.2022
Session Time
13:00 - 14:30
Room
Industry session hall 1
Session Icon
Fully Live
Lecture Time
14:05 - 14:25

Closing remarks

Session Type
Industry
Date
Mon, 06.06.2022
Session Time
13:00 - 14:30
Room
Industry session hall 1
Session Icon
Fully Live
Lecture Time
14:25 - 14:30